Freyr: Redefining Regulatory Solutions for the Bio-Pharma Sector
Owing to technological advances and a record number of drug approvals, the Biopharma sector seems has fared well in the past decade. However, to thrive in the market, companies need to be dynamic and flexible for rapid product expansions, accelerated new market access, etc. That forces them to look for agile and flexible partners who can adapt to the changing landscape of biopharma sector.Freyr, based out of Hyderabad, has the Regulatory expertise to offer solutions to a large network of countries and has been redefining Regulatory solutions globally.
Freyr caters three major solutions to large, small and mid sized BioPharma companies. These service includes Global Regulatory Strategy Consulting, Centralized Outsourcing of Regulatory Functions apart from offering Cloud-based Regulatory software solutions under one roof. The company provides IP/Solution design, development and even remote deployment services,“While there are companies that offer one of the three solutions, Freyr is uniquely positioned to cater to all the three Regulatory requirements, there by offering a single entity for the entire Regulatory value chain be it new product launch or life cycle management of legacy products,” elaborates Rajiv Rangan, CEO Freyer.
Freyr also provided a software called Freyr SUBMIT a publishing software which Addressing the industry's need for a robust Regulatory publishing software to streamline and effectively manage the entire clinical Lifecycle. Freyr caters Freyr SUBMIT,a publishing submission software.“Freyr SUBMIT has a robust validation engine and audit trail functionalities that ensure an error free submission. The Solution also has pre built country specific templates for managing the submission lifecycle effectively. Freyr SUBMIT has a SUBMIT Trak module that helps track and manage global submission projects,” states suren dheenadayalan Co-CEO Freyr SPAR an Integrated, light – weight and cloud - based global Regulatory Information Management (RIM) solution is garnering market attention globally.
Freyr also offers a Regulatory document management system called rDMS, which is one of the easiest to configure meta data management modules to configure. It has a 'Doc Groups' feature that allows a loosely decoupled meta data architecture, that is easy to use and enables even end users to handle meta data effectively without the need of having a technical person. The company's Award - winning Freyr GRX accelerated submissions delivery solution provides accelerated and compliant regulatory Strategy - to Submission Services.
All the Freyr software solutions are designed, delivered and supported all over the world and are extremely cost effective with flexible subscription and licensing models and this is what differentiates Freyr from competitors. "We have constantly been told that our flexibility, accelerated support and attention to clients far exceed the experience our clients had from other large solution providers. From a product feature perspective, we are constantly updating our solutions aligned with latest technology and latest Regulatory guidelines. We are seamlessly interconnected to provide out-of-the box solutions that are up to date from a Regulatory perspective,” opines Rajiv.
In the next five years, the company aims at becoming a global leader in Regulatory solutions for all markets across the globe and all product categories pharma, Biotech, Medical Devices and Consumer Healthcare Industries.
Freyr also offers a Regulatory document management system called rDMS, which is one of the easiest to configure meta data management modules to configure. It has a 'Doc Groups' feature that allows a loosely decoupled meta data architecture, that is easy to use and enables even end users to handle meta data effectively without the need of having a technical person. The company's Award - winning Freyr GRX accelerated submissions delivery solution provides accelerated and compliant regulatory Strategy - to Submission Services.
All the Freyr software solutions are designed, delivered and supported all over the world and are extremely cost effective with flexible subscription and licensing models and this is what differentiates Freyr from competitors. "We have constantly been told that our flexibility, accelerated support and attention to clients far exceed the experience our clients had from other large solution providers. From a product feature perspective, we are constantly updating our solutions aligned with latest technology and latest Regulatory guidelines. We are seamlessly interconnected to provide out-of-the box solutions that are up to date from a Regulatory perspective,” opines Rajiv.
In the next five years, the company aims at becoming a global leader in Regulatory solutions for all markets across the globe and all product categories pharma, Biotech, Medical Devices and Consumer Healthcare Industries.
